Cascade viscoelastic micro-fluidic chip as well as preparation method and application thereof

Through the design of cascaded viscoelastic microfluidic chips, the use of PEO solution to provide elastic force, and efficient sorting of multiple CTCs from whole blood is achieved, solving the problems of complex sorting, high cost and low purity in the existing technology. , realizes high-throughput, high-purity CTC sorting, suitable for cancer research.

CN119056506AActive Publication Date: 2024-12-03SHANGHAI JIAOTONG UNIV

Patent Information

Application Number
CN202411180311.0
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-27
Publication Date
2024-12-03
Estimated Expiration
2044-08-27

AI Technical Summary

Technical Problem

The prior art is difficult to efficiently and accurately sort multiple circulating tumor cells (CTCs) from whole blood samples at the same time, especially in the low-load stage of tumors. The traditional method is disturbed by high-abundance blood cells in peripheral blood, and is complex in operation and high in cost. , it is impossible to directly select multiple types of CTCs from whole blood.

Method used

A cascaded viscoelastic microfluidic chip is designed, including a hemofiltration module and a CTC sorting module, which provides additional elastic force by introducing PEO solution to achieve simultaneous sorting of A549 and A549 from undiluted whole blood samples. The two types of CTCs in MCF-7 use transition sections to cascade the blood filtration module and the CTC sorting module in series. It has a simple structure, large flux and high sorting purity.

Benefits of technology

It realizes efficient and direct selection of multiple CTCs from whole blood, breaks through the technical bottleneck of single CTC sorting, improves sample processing flux and sorting purity, reduces cell damage, is simple to operate, and is suitable for cancer metastasis mechanism Research and tumor drug development.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119056506A_ABST
    Figure CN119056506A_ABST
Patent Text Reader

Abstract

The invention provides a cascade viscoelastic micro-fluidic chip and a preparation method and application thereof, and belongs to the technical field of CTC sorting, and the cascade viscoelastic micro-fluidic chip comprises a blood filtering module, a transition section and a CTC sorting module. The blood filtering module is composed of a first inlet, a second inlet, a first annular bifurcated branch, a first straight channel section, a first amplification section and a first outlet. The CTC sorting module is composed of a third inlet, a second annular bifurcated branch, a second straight channel section, a second amplification section, a second outlet and a third outlet. And the blood filtering module and the CTC sorting module are cascaded in series by utilizing the transition section. According to the cascaded viscoelastic micro-fluidic chip as well as the preparation method and the application thereof, the cascaded viscoelastic micro-fluidic chip has the advantages of large sample treatment flux, high sorting purity, small structural size, no need of cell modification, simplicity in operation and the like; and the two CTCs, namely A549 and MCF-7, can be simultaneously separated from an undiluted whole blood sample.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the technical field of CTC high-throughput sorting, and in particular to a cascade viscoelastic microfluidic chip and a preparation method and application thereof. Background Art

[0002] Cancer metastasis is the main cause of cancer-related deaths. Prompt treatment of patients in the early stages of cancer metastasis can reduce cancer deaths by about 30%. Therefore, studying the mechanism of cancer metastasis and early precision diagnosis and treatment technology is a key means for humans to fight cancer in the future. However, in the early stages of cancer metastasis, the patient's tumor load is extremely low, making it difficult to locate metastatic lesions through traditional imaging methods, and it is impossible to extract tumor cells through puncture biopsy technology, which greatly limits the molecular diagnosis of early metastatic tumors, precision treatment, and research on the mechanisms of cancer occurrence, development, and metastasis.

[0003] Circulating tumor cells (CTC) refer to tumor cells that fall off from primary or metastatic tumor lesions, undergo epithelial-mesenchymal transition and enter the peripheral blood circulation. A large number of studies have shown that CTCs are already present in the peripheral blood at the low tumor load stage. Therefore, CTC liquid biopsy technology can break the limitation that tissue biopsy is only applicable to solid tumor tissues detectable by imaging. At the same time, with the characteristics of being non-invasive, easy to sample, and dynamically observable, it can display the biological information of the tumor in real time, comprehensively, and accurately, showing unique advantages in early cancer diagnosis and treatment guidance.

[0004] However, due to the interference of high-abundance blood cells in peripheral blood, high-throughput and accurate separation of CTCs is still a huge challenge. Active manipulation of cell sorting technology usually requires the use of complex instruments and equipment and the introduction of additional manual operations to complete the sorting of CTCs because it relies on external forces. Therefore, active manipulation of cell sorting methods usually face problems such as high technical cost, difficulty in small modularization, and complex operation. The existing passive manipulation of cell sorting technology can avoid the disadvantages of the above-mentioned active manipulation methods, but before sorting, red blood cells usually need to be lysed and the blood diluted dozens of times, and CTCs cannot be directly sorted from whole blood samples. The sample processing throughput is still limited, and passive sorting technology still has problems such as high cell shear stress and severe blockage. In addition, most current studies can only achieve the separation of a specific type of CTC from the blood, and have not yet achieved the simultaneous sorting of multiple types of CTCs directly from whole blood. Therefore, a new cell sorting technology is proposed that can quickly, accurately and directly separate multiple CTCs from whole blood, which is of great significance for the study of cancer metastasis mechanism and the development of tumor drugs. Summary of the invention

[0005] The object of the present invention is to provide a cascade viscoelastic microfluidic chip and a preparation method and application thereof. The cascade viscoelastic microfluidic chip has the advantages of large sample processing throughput, high sorting purity, small structural size, no need for cell modification and simple operation, and can simultaneously sort out two types of CTCs, A549 and MCF-7, from undiluted whole blood samples.

[0006] To achieve the above object, the present invention provides a cascade viscoelastic microfluidic chip, comprising a blood filtration module, a transition section and a CTC sorting module, wherein the transition section cascades the blood filtration module and the CTC sorting module in series;

[0007] The blood filtration module comprises an inlet 1, an inlet 2, a circular bifurcated branch 1, a straight channel section 1, and an enlarged section 1 which are connected in sequence, wherein the initial end of the circular bifurcated branch 1 is connected to the end of the inlet 1, the end of the circular bifurcated branch 1 is connected to the straight channel section 1, the end of the enlarged section 1 is connected to the initial end of the transition section, and the enlarged section 1 is also connected to two symmetrically arranged outlets 1;

[0008] The CTC sorting module includes an inlet three, a circular bifurcated branch road two, a straight channel section two, an amplifying section two, an outlet two and an outlet three. The initial end of the circular bifurcated branch road two is connected to the end of the transition section, the end of the circular bifurcated branch road two is connected to the straight channel section two, the outlet two and the outlet three are both connected to the end of the amplifying section two, the outlet three is connected to the middle position of the amplifying section two, and two outlets are provided, which are symmetrically arranged about the outlet three.

[0009] Preferably, the height of all channels in the cascade viscoelastic microfluidic chip is 50 μm, the length and width of the straight channel section 1 and the straight channel section 2 are 38 mm and 120 μm respectively, the width of the amplification section 1 and the amplification section 2 is 1080 μm, the width of the outlet 1 and the outlet 2 is 356 μm, and the width of the outlet 3 is 280 μm;

[0010] The whole blood sample in the inlet one is introduced into the straight channel section one together with the sheath fluid one in the inlet two through the circular bifurcation branch one with a ring width of 120 μm, and the blood cell-free sample solution flowing out of the blood filtration module is introduced into the straight channel section two together with the sheath fluid two in the inlet three after passing through the transition section.

[0011] Preferably, the sheath liquid 1 and the sheath liquid 2 are prepared by dissolving a powder of a high molecular weight polymer polyethylene oxide in deionized water to obtain a PEO solution, wherein the concentration of the sheath liquid 1 is 0.04% to 0.06% w / v, and the concentration of the sheath liquid 2 is 0.13% to 0.17% w / v.

[0012] Preferably, the flow rates at the inlet one, the inlet two and the inlet three are 1.2-1.8 mL / h, 8-10 mL / h and 15-17 mL / h respectively.

[0013] The present invention also provides a method for preparing the cascade viscoelastic microfluidic chip as described above, comprising the following steps:

[0014] S1. Mix polydimethylsiloxane and polydimethylsiloxane curing agent in a mass ratio of 10:1, and stir with a glass rod for 7 to 10 minutes to fully mix them to obtain a polydimethylsiloxane mixed solution;

[0015] S2, placing the polydimethylsiloxane mixed solution in step S1 in a vacuum drying dish, and removing bubbles in the polydimethylsiloxane mixed solution by vacuuming to obtain a polydimethylsiloxane mixed solution after the bubbles are removed;

[0016] S3, placing the silicon wafer with the channel pattern of the cascade viscoelastic microfluidic chip in a cell culture dish, and introducing the polydimethylsiloxane mixed solution after the bubbles are removed in step S2, and after the polydimethylsiloxane mixed solution completely and evenly covers the surface of the silicon wafer, placing it in a vacuum drying dish again to evacuate and remove the bubbles between the silicon wafer and the bottom of the cell culture dish;

[0017] S4, placing the cell culture dish in step S3 in an oven for curing;

[0018] S5, taking out the cell culture dish of step S4, separating the solidified polydimethylsiloxane from the silicon wafer, cutting it into a rectangular shape, and using a puncher to punch holes at the positions of inlet 1, inlet 2, inlet 3, outlet 1, outlet 2 and outlet 3;

[0019] S6, using transparent tape to remove the pattern surface of the polydimethylsiloxane and the surface of the glass slide in step S5, and putting the polydimethylsiloxane and the glass slide into a plasma cleaning machine;

[0020] S7, turn on the vacuum pump connected to the plasma cleaning machine in step S6, when the pressure in the plasma cleaning machine chamber drops to 200Pa, stop evacuating and turn on the glow, start timing when a purple-red glow appears in the vacuum chamber, stop the glow after 50 seconds and take out the two;

[0021] S8, closely attach the patterned surface of polydimethylsiloxane to the glass slide, gently press to remove bubbles between the surfaces, and then place on a heating table to further strengthen the bonding effect;

[0022] S9. Insert the polytetrafluoroethylene capillary into the hole of the cascade viscoelastic microfluidic chip, and pour the polydimethylsiloxane mixture at the position, and place it in an oven to enhance the sealing performance of all outlet and inlet positions.

[0023] Preferably, in step S2, the vacuuming time is 50 to 70 minutes.

[0024] Preferably, in step S3, the vacuuming time is 20 to 30 minutes.

[0025] Preferably, in step S4 and step S9, the oven temperature is set to 80° C. and the time is set to 50 to 60 minutes.

[0026] Preferably, in step S8, the temperature of the heating stage is set to 85° C. for 40 to 50 minutes.

[0027] The present invention also provides an application of the cascade viscoelastic microfluidic chip described above for simultaneously separating A549 and MCF-7 from whole blood, comprising the following steps:

[0028] a. Pour 600 kDa PEO powder into 50 mL of deionized water and shake for 28 to 30 hours to prepare a stock solution with a PEO concentration of 1% to 2% w / v;

[0029] b. diluting the stock solution with a concentration of 1% to 2% w / v into a working solution with a PEO concentration of 0.04% to 0.06% w / v and a working solution with a PEO concentration of 0.13% to 0.17% w / v, which are used as sheath liquid 1 and sheath liquid 2, respectively;

[0030] c. Use three syringe pumps to inject the whole blood sample after adding A549 and MCF-7, 0.04%-0.06% w / v working solution and 0.13%-0.17% w / v working solution into the cascade viscoelastic microfluidic chip from inlet 1, inlet 2 and inlet 3, respectively. The flow rates at inlet 1, inlet 2 and inlet 3 are 1.2-1.8 mL / h, 8-10 mL / h and 15-17 mL / h, respectively.

[0031] d. Collect A549 and MCF-7 from outlet 2 and outlet 3, respectively.

[0032] Therefore, the present invention adopts the above-mentioned cascade viscoelastic microfluidic chip and preparation method and application, and the beneficial technical effects are as follows:

[0033] (1) The cascade viscoelastic microfluidic chip of the present invention generates additional elastic force on cells in the blood by introducing PEO solution, breaking the limitation that the fluid medium of traditional inertial microfluidics must be Newtonian fluid. It can directly sort CTCs from the blood, avoiding the operations of lysing red blood cells and diluting samples before sorting, thereby improving the sample processing throughput and making the operation simpler.

[0034] (2) The cascade viscoelastic microfluidic chip of the present invention utilizes a transition section to cascade the blood filtration module and the CTC sorting module in series, which can achieve the simultaneous sorting of two types of CTCs, A549 and MCF-7, breaking through the technical bottleneck of existing research that can only sort a specific CTC;

[0035] (3) The cascade viscoelastic microfluidic chip of the present invention has a simple structure and a smaller area than the traditional spiral microfluidic chip structure, which is conducive to further improving the sorting throughput through parallel design;

[0036] (4) The cascade viscoelastic microfluidic chip of the present invention uses the force of fluid acting on cells to achieve sorting, which effectively reduces the probability of cells directly colliding with the microstructure, can reduce cell damage during the sorting process, and improve the integrity of cells after sorting. BRIEF DESCRIPTION OF THE DRAWINGS

[0037] Figure 1 This is the working principle diagram of the cascade viscoelastic microfluidic chip;

[0038] Figure 2 Schematic diagram of the movement in the channel of the cascade viscoelastic microfluidic chip;

[0039] Figure 3 This is the overall design diagram of the cascade viscoelastic microfluidic chip;

[0040] Figure 4 It is a partial design diagram of the cascade viscoelastic microfluidic chip at the beginning of the straight channel section 1 and the straight channel section 2;

[0041] Figure 5 This is a partial design diagram of the cascade viscoelastic microfluidic chip at the amplification section one and the amplification section two.

[0042] Reference numerals

[0043] 1. Blood filtration module; 11. Entrance one; 12. Entrance two; 13. Circular bifurcation branch one; 14. Straight channel section one; 15. Amplification section one; 16. Exit one; 2. Transition section; 3. CTC sorting module; 31. Entrance three; 32. Circular bifurcation branch two; 33. Straight channel section two; 34. Amplification section two; 35. Exit two; 36. Exit three. DETAILED DESCRIPTION

[0044] The technical solution of the present invention is further described below through the accompanying drawings and embodiments.

[0045] Unless otherwise defined, technical or scientific terms used in the present invention shall have the common meanings understood by one having ordinary skills in the field to which the present invention belongs.

[0046] Embodiment 1

[0047] like Figure 1 As shown, the present invention proposes a cascade viscoelastic microfluidic chip, comprising a blood filtration module 1, a transition section 2 and a CTC sorting module 3. The transition section 2 cascades the blood filtration module 1 and the CTC sorting module 3 in series.

[0048] The blood filtration module 1 includes an inlet 11, an inlet 2 12, a circular bifurcated branch 13, a straight channel section 14, and an enlarged section 15 which are connected in sequence. The initial end of the circular bifurcated branch 13 is connected to the end of the inlet 11, the end of the circular bifurcated branch 13 is connected to the straight channel section 14, the end of the enlarged section 15 is connected to the initial end of the transition section 2, and the enlarged section 15 is also connected to two symmetrically arranged outlets 16;

[0049] The CTC sorting module 3 includes an inlet three 31, a circular bifurcated branch 2 32, a straight channel section 2 33, an enlarged section 2 34, an outlet two 35 and an outlet three 36. The initial end of the circular bifurcated branch 2 32 is connected to the end of the transition section 2, the end of the circular bifurcated branch 2 32 is connected to the straight channel section 2 33, the outlet two 35 and the outlet three 36 are both connected to the end of the enlarged section 2 34, the outlet three 36 is connected to the middle position of the enlarged section 2 34, and there are two outlets 2 35, which are symmetrically arranged about the outlet three 36.

[0050] Three injection pumps were used to inject whole blood samples, sheath fluid 1 and sheath fluid 2 into the cascade viscoelastic microfluidic chip from inlet 1 11, inlet 2 12 and inlet 3 31, respectively. The flow rates at inlet 1 11, inlet 2 12 and inlet 3 31 were 1.5 mL / h, 9 mL / h and 16 mL / h, respectively.

[0051] Sheath liquid 1 and sheath liquid 2 are prepared by dissolving powder of high molecular weight polymer polyethylene oxide in deionized water to obtain PEO solutions, wherein the concentration of sheath liquid 1 is 0.04% to 0.06% w / v, and the concentration of sheath liquid 2 is 0.13% to 0.17% w / v.

[0052] like Figure 2 As shown, the whole blood sample will reach the beginning of the straight channel section 14 through the circular bifurcation branch 13. Since the sheath fluid 1 is introduced from the inlet 2 12, the cells will be subject to inertial lift when moving in the straight channel section 14. Elastic force and the viscous drag F d ~a p The combined effect of F i and F e Play a leading role; p is the cell diameter. Due to the small size of red blood cells and white blood cells, eDue to the repulsive effect of the sample, it cannot completely penetrate the sample-sheath interface and eventually reaches equilibrium near the interface. i F e The repulsive effect of F e The direction originally pointing to the channel wall will be changed to the middle of the channel, pushing A549 and MCF-7 to migrate further to the center of the channel to reach the equilibrium position. Therefore, blood cells and two CTCs will have a lateral position difference in the straight channel section 14, and this difference will be further increased when the cells enter the amplification section 15, so that red blood cells and white blood cells flow into the outlet 16, while A549 and MCF-7 enter the CTC sorting module 3 through the transition section 2, realizing the separation of blood cells and two CTCs.

[0053] like Figure 2 As shown, A549 and MCF-7 can be separated in the CTC sorting module 3 and flow out from the outlet 2 35 and the outlet 3 36 respectively. The sorting principle is the same as that of the above-mentioned blood cells and the two CTCs.

[0054] like Figure 3 to Figure 5 As shown, the length and width of the straight channel section 1 14 and the straight channel section 2 33 are 38 mm and 120 μm respectively, the width of the enlarged section 1 15 and the enlarged section 2 34 is 1080 μm, the width of the outlet 1 16 and the outlet 2 35 is 356 μm, the width of the outlet 3 36 is 280 μm, the width of the circular bifurcation branch 1 13 and the circular bifurcation branch 2 32 is 120 μm, and the height of all channels in the cascade viscoelastic microfluidics is 50 μm.

[0055] The working principle of the present invention is as follows:

[0056] After the whole blood sample enters the cascade viscoelastic microfluidic chip from inlet 11, it will follow the sheath fluid 1 flowing in from inlet 2 12 into the straight channel section 14 in the blood filtration module 1. The blood cells and the two CTCs will have a lateral position difference in the straight channel section 14, and the difference will be further amplified after the cells enter the amplification section 15, so that the red blood cells and white blood cells flow out from the outlet 16, while A549 and MCF-7 enter the CTC sorting module 3 through the transition section 2. Based on the same principle, A549 and MCF-7 will be split and flow out from the outlet 2 35 and the outlet 3 36 after passing through the straight channel section 2 33 and the amplification section 2 34, thereby achieving the goal of simultaneously sorting A549 and MCF-7 from the whole blood sample.

[0057] Therefore, the present invention adopts the above-mentioned cascade viscoelastic microfluidic chip, preparation method and application. The cascade viscoelastic microfluidic chip has the advantages of large sample processing throughput, high sorting purity, small structure size, no need for cell modification and simple operation, and can simultaneously sort out two types of CTCs, A549 and MCF-7, from undiluted whole blood samples; the sorted A549 and MCF-7 are used for downstream analysis, including immunoblotting, fluorescence flow cytometry, and mass spectrometry flow cytometry.

[0058] Finally, it should be noted that the above embodiments are only used to illustrate the technical solution of the present invention rather than to limit it. Although the present invention has been described in detail with reference to the preferred embodiments, those skilled in the art should understand that they can still modify or replace the technical solution of the present invention with equivalents, and these modifications or equivalent replacements cannot cause the modified technical solution to deviate from the spirit and scope of the technical solution of the present invention.

Claims

1. A cascade viscoelastic microfluidic chip, It is characterized in that It includes a blood filtration module, a transition section and a CTC sorting module, wherein the transition section cascades the blood filtration module and the CTC sorting module in series; The blood filtration module comprises an inlet 1, an inlet 2, a circular bifurcated branch 1, a straight channel section 1, and an enlarged section 1 which are connected in sequence, wherein the initial end of the circular bifurcated branch 1 is connected to the end of the inlet 1, the end of the circular bifurcated branch 1 is connected to the straight channel section 1, the end of the enlarged section 1 is connected to the initial end of the transition section, and the enlarged section 1 is also connected to two symmetrically arranged outlets 1; The CTC sorting module includes an inlet three, a circular bifurcated branch road two, a straight channel section two, an amplifying section two, an outlet two and an outlet three. The initial end of the circular bifurcated branch road two is connected to the end of the transition section, the end of the circular bifurcated branch road two is connected to the straight channel section two, the outlet two and the outlet three are both connected to the end of the amplifying section two, the outlet three is connected to the middle position of the amplifying section two, and two outlets are provided, which are symmetrically arranged about the outlet three.

2. The cascade viscoelastic microfluidic chip according to claim 1, It is characterized in that The height of all channels in the cascade viscoelastic microfluidic chip is 50 μm, the length and width of the straight channel section 1 and the straight channel section 2 are 38 mm and 120 μm respectively, the width of the enlarged section 1 and the enlarged section 2 is 1080 μm, the width of the outlet 1 and the outlet 2 is 356 μm, and the width of the outlet 3 is 280 μm; The whole blood sample in the inlet one is introduced into the straight channel section one together with the sheath fluid one in the inlet two through the circular bifurcation branch one with a ring width of 120 μm, and the blood cell-free sample solution flowing out of the blood filtration module is introduced into the straight channel section two together with the sheath fluid two in the inlet three after passing through the transition section.

3. The cascade viscoelastic microfluidic chip according to claim 2, It is characterized in that The sheath liquid 1 and sheath liquid 2 are prepared by dissolving the powder of high molecular weight polymer polyethylene oxide in deionized water to obtain PEO solutions, wherein the concentration of sheath liquid 1 is 0.04% to 0.06% w / v, and the concentration of sheath liquid 2 is 0.13% to 0.17% w / v.

4. The cascade viscoelastic microfluidic chip according to claim 3, It is characterized in that The flow rates at the inlet one, the inlet two and the inlet three are 1.2-1.8 mL / h, 8-10 mL / h and 15-17 mL / h respectively.

5. A method for preparing the cascade viscoelastic microfluidic chip according to any one of claims 1 to 4, It is characterized in that The following steps are involved: S1. Mix polydimethylsiloxane and polydimethylsiloxane curing agent in a mass ratio of 10:1, and stir with a glass rod for 7 to 10 minutes to fully mix them to obtain a polydimethylsiloxane mixed solution; S2, placing the polydimethylsiloxane mixed solution in step S1 in a vacuum drying dish, and removing bubbles in the polydimethylsiloxane mixed solution by vacuuming to obtain a polydimethylsiloxane mixed solution after the bubbles are removed; S3, placing the silicon wafer with the channel pattern of the cascade viscoelastic microfluidic chip in a cell culture dish, and introducing the polydimethylsiloxane mixed solution after the bubbles are removed in step S2, and after the polydimethylsiloxane mixed solution completely and evenly covers the surface of the silicon wafer, placing it in a vacuum drying dish again to evacuate and remove the bubbles between the silicon wafer and the bottom of the cell culture dish; S4, placing the cell culture dish in step S3 in an oven for curing; S5, taking out the cell culture dish of step S4, separating the solidified polydimethylsiloxane from the silicon wafer, cutting it into a rectangular shape, and using a puncher to punch holes at the positions of inlet 1, inlet 2, inlet 3, outlet 1, outlet 2 and outlet 3; S6, using transparent tape to remove the pattern surface of the polydimethylsiloxane and the surface of the glass slide in step S5, and putting the polydimethylsiloxane and the glass slide into a plasma cleaning machine; S7, turn on the vacuum pump connected to the plasma cleaning machine in step S6, when the pressure in the plasma cleaning machine chamber drops to 200Pa, stop evacuating and turn on the glow, start timing when a purple-red glow appears in the vacuum chamber, stop the glow after 50 seconds and take out the two; S8, closely attach the patterned surface of polydimethylsiloxane to the glass slide, gently press to remove bubbles between the surfaces, and then place on a heating table to further strengthen the bonding effect; S9. Insert the polytetrafluoroethylene capillary into the hole of the cascade viscoelastic microfluidic chip, and pour the polydimethylsiloxane mixture at the position, and place it in an oven to enhance the sealing performance of all outlet and inlet positions.

6. The method for preparing a cascade viscoelastic microfluidic chip according to claim 5, It is characterized in that In step S2, the vacuuming time is 50 to 70 minutes.

7. The method for preparing a cascade viscoelastic microfluidic chip according to claim 5, It is characterized in that In step S3, the vacuuming time is 20 to 30 minutes.

8. The method for preparing a cascade viscoelastic microfluidic chip according to claim 5, It is characterized in that In step S4 and step S9, the oven temperature is set to 80° C. and the time is set to 50 to 60 minutes.

9. The method for preparing a cascade viscoelastic microfluidic chip according to claim 5, It is characterized in that In step S8, the temperature of the heating stage is set to 85°C for 40 to 50 minutes.

10. Use of the cascade viscoelastic microfluidic chip as claimed in claim 1 for simultaneously separating A549 and MCF-7 from whole blood, It is characterized in that The following steps are involved: a. Pour 600 kDa PEO powder into deionized water and shake for 28 to 30 hours to prepare a stock solution with a PEO concentration of 1% to 2% w / v; b. diluting the stock solution with a concentration of 1% to 2% w / v into a working solution with a PEO concentration of 0.04% to 0.06% w / v and a working solution with a PEO concentration of 0.13% to 0.17% w / v, which are used as sheath liquid 1 and sheath liquid 2, respectively; c. Use three syringe pumps to inject the whole blood sample after adding A549 and MCF-7, 0.04%-0.06% w / v working solution and 0.13%-0.17% w / v working solution into the cascade viscoelastic microfluidic chip from inlet 1, inlet 2 and inlet 3, respectively. The flow rates at inlet 1, inlet 2 and inlet 3 are 1.2-1.8 mL / h, 8-10 mL / h and 15-17 mL / h, respectively. d. Collect A549 and MCF-7 from outlet 2 and outlet 3, respectively.

Citation Information

Patent Citations

  • Microfluidic device for sorting cells and methods for using same

    CN107674820A

  • Cell separation device

    CN107746794A

  • Microfluidic device for sorting micron particles

    CN110124757A

  • Micro-fluidic chip detection system and method for cell sorting and focusing

    CN111592965A

  • Cell multistage sorting microfluidic chip integrating viscoelasticity and magnetic force

    CN111647499A

Cited By

  • Biological detection chip, detection method and detection equipment

    CN119738236A

  • Multi-channel viscoelastic micro-fluidic chip, manufacturing method and method for separating MCF-7 cells

    CN120394110A